Key result
Women with systemic lupus erythematosus had a higher risk of carotid plaque progression over 5 years compared to controls (31.5% vs 15%; RR 2.09, 95% CI 1.30 to 3.37).
Why the study?
The study was conducted to investigate the occurrence of and risk factors for the progression of carotid intima media thickness and plaque in women with and without systemic lupus erythematosus.
What are the risk factors for progression of carotid IMT and plaque in women with SLE compared to controls?
Cohort (n=275)
What are the risk factors for progression of carotid IMT and plaque in women with SLE compared to controls?
Effect estimate: RR 2.09 (95% CI 1.30 to 3.37)
Absolute Event Rate: 31.5% vs 15%
Women with SLE have a significantly higher risk of carotid plaque progression over 5 years compared to controls, with higher fasting glucose, larger waist circumference, and non-use of hydroxychloroquine identified as modifiable risk factors.
May warrant closer vascular monitoring in women with SLE; leaves open whether modifiable factors alter plaque progression.
OBJECTIVE: To investigate the occurrence of and risk factors for progression of carotid intima media thickness (IMT) and plaque in women with and without SLE. METHODS: A cohort of 149 women with SLE and 126 controls participated in SOLVABLE (Study of Lupus Vascular and Bone Long-term Endpoints). Demographics, cardiovascular and SLE factors, and laboratory assessments were collected at baseline. Carotid IMT and plaque were measured using B-mode ultrasound at baseline and at 5-year follow-up. Regression models were used to identify predictors of progression in carotid IMT and plaque; multivariate models were adjusted for age, hypertension and total cholesterol to high-density lipoprotein ratio. RESULTS: The mean±SD follow-up time was 5.35±0.60 years in cases and 5.62±0.66 years in controls. The mean IMT change per year was 0.008±0.015 mm in cases and 0.005±0.019 mm in controls (p=0.24). At follow-up, 31.5% of cases and 15% of controls had plaque progression, with a relative risk for plaque progression of 2.09 (95% CI 1.30 to 3.37). In SLE cases, higher fasting glucose and lower fibrinogen were associated with IMT progression after adjustment. Larger waist circumference and non-use of hydroxychloroquine were associated with plaque progression after adjustment. CONCLUSION: Potential modifiable risk factors for carotid IMT and plaque progression in women with SLE were identified, suggesting that monitoring of glucose and waist circumference and use of hydroxychloroquine may be beneficial.
No takes yet. Share an insight, caveat, or question.
Lertratanakul et al. (2021) conducted a cohort in Systemic lupus erythematosus (n=275). Systemic lupus erythematosus vs. Controls without systemic lupus erythematosus was evaluated on Progression of carotid IMT and plaque (RR 2.09, 95% CI 1.30 to 3.37). Women with systemic lupus erythematosus had a higher risk of carotid plaque progression over 5 years compared to controls (31.5% vs 15%; RR 2.09, 95% CI 1.30 to 3.37).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: